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Abstract
The role of actin dynamics in clathrin-mediated endocytosis in mammalian cells is unclear. In this study, we define the role
of actin cytoskeleton in Kaposi’s sarcoma-associated herpesvirus (KSHV) entry and trafficking in endothelial cells using an
immunofluorescence-based assay to visualize viral capsids and the associated cellular components. In contrast to infectivity
or reporter assays, this method does not rely on the expression of any viral and reporter genes, but instead directly tracks
the accumulation of individual viral particles at the nuclear membrane as an indicator of successful viral entry and trafficking
in cells. Inhibitors of endosomal acidification reduced both the percentage of nuclei with viral particles and the total
number of viral particles docking at the perinuclear region, indicating endocytosis, rather than plasma membrane fusion, as
the primary route for KSHV entry into endothelial cells. Accordingly, a viral envelope protein was only detected on
internalized KSHV particles at the early but not late stage of infection. Inhibitors of clathrin- but not caveolae/lipid raft-
mediated endocytosis blocked KSHV entry, indicating that clathrin-mediated endocytosis is the major route of KSHV entry
into endothelial cells. KSHV particles were colocalized not only with markers of early and recycling endosomes, and
lysosomes, but also with actin filaments at the early time points of infection. Consistent with these observations, transferrin,
which enters cells by clathrin-mediated endocytosis, was found to be associated with actin filaments together with early
and recycling endosomes, and to a lesser degree, with late endosomes and lysosomes. KSHV infection induced dynamic
actin cytoskeleton rearrangements. Disruption of the actin cytoskeleton and inhibition of regulators of actin nucleation such
as Rho GTPases and Arp2/3 complex profoundly blocked KSHV entry and trafficking. Together, these results indicate an
important role for actin dynamics in the internalization and endosomal sorting/trafficking of KSHV and clathrin-mediated
endocytosis in endothelial cells.
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Introduction
Endocytosis is a constitutive cellular process that results in the
internalization of cell surface receptors and ligands, and
membrane components, often initiating the activation of signal
transduction cascades [1]. The endocytic pathway is often
exploited by a variety of pathogens to gain entry into the cells [2].
The best-described endocytic pathway is clathrin-mediated
endocytosis [3]. In this process, the clathrin-coated pits assemble at
the plasma membrane and acquire cargo. The plasma membrane
proceeds to invaginate and constrict to generate a clathrin-coated
vesicle, which is subsequently transported to the interior of the cell,
where it loses its clathrin coat and fuses with the early endosome
[3]. The orderly transport of endocytic cargo from the cell exterior
to the interior is highly regulated, and requires the participation of
numerous lipid components and accessory proteins, as well as
alterations of fine cellular structures and controlled mechanical
force to overcome the physical resistance and propel the vesicle
into the cell [4].
The actin cytoskeleton has been proposed to participate in either a
structural role in clathrin-mediated endocytosis, or by providing the
mechanical force necessary to complete endocytosis [5,6]. The
evidence for a role of actin in this process primarily comes from
studies of yeast, in which actin dynamic assembly and disassemblyare
essential for endocytosis [7–9]. However, the role of actin in
endocytosis in mammalian cells is less clear [5,10–12]. Studies have
shown a close association between components of the endocytic
machinery and actin cytoskeleton [13] while regulators of actin
polymerization such as Arp2/3 and neural Wiskott-Aldrich syn-
dromeprotein (N-WASP) are found to be recruited to clathrin-coated
vesicles during endocytosis [14]. However, chemical disruption of
actin dynamics has resulted in only partial inhibition of endocytosis in
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tosis in the entire population of cells, it is possible that the results may
have been confounded by the use of an alternate non-clathrin-
dependent pathway, or the requirement for actin in only specific
subsets of clathrin-coated vesicles [16]. In addition, since mammalian
cells use actintomaintain plasmamembrane tension, reduced plasma
membrane tension caused by actin disruption may actually enhance
invaginations during the initiation of endocytosis [17–19]. Endocy-
tosis occurring at the apical surface of MDCK cells seems to be actin-
dependent, while basolateral endocytosis does not appear to require
an intact actin network [15]. Internalization of influenza virus by
epithelial cells requires an intact actin cytoskeleton at the apical
surface, while viral entry at the basolateral surface did not [20]. More
recent studies using total internal reflection fluorescence microscopy
(TIR-FM) technology to observe individual endocytic events
recorded a burst of actin polymerization with concomitant
internalization of clathrin-coated pits and movement of clathrin-
coated vesicles into the cell interior, but did not determine the
potential effects of actin disruption on these events [16,21,22].
The subcortical actin network that lies immediately beneath the
plasma membrane is tethered to the membrane via linking
molecules such as ezrin [23] and cortactin [24], and may
participate in endocytosis by providing the mechanical force to
deform the plasma membrane, allowing invagination and scission
of clathrin-coated pits and/or caveolae pits [5]. Actin may also
participate in later steps of the endocytic pathway by facilitating
the movement of endosomes towards the cell interior [5,16].
However, the exact role of the actin cytoskeleton in endosomal
sorting and trafficking remains largely unknown.
The dynamic nature of the actin cytoskeleton is essential for its
function; existing actin filaments undergo severing and depoly-
merization in response to cellular requirements and stimuli [25,26]
while new actin filaments are polymerized from monomeric actin
subunits and by branching off from existing filaments [27]. These
processes are regulated by Rho GTPases, WASP/N-WASP/
WAVE, the ARP2/3 complex, and the formin family of actin-
binding proteins [27–29].
Studies of clathrin-mediated endocytosis typically utilize fluor-
escently labeled molecules such as transferrin to assess the role of
various accessory and regulatory proteins in endocytosis. Although
transferrin and its receptor are well-known to be internalized via
clathrin-mediated endocytosis, they primarily enter the recycling
endosomal pathway [30–34], and thus, may not be entirely
relevant to molecules that progress to other endosomal pathways,
such as the lysosomal pathway. Several microbial pathogens
exploit the endocytic pathway to gain access into the cell interior
[2], and some such as Listeria monocytogenes are also known to
specifically manipulate the actin cytoskeleton to travel through the
cell [35–37]. However, viruses, which are inert particles that rely
on existing cellular pathways to enter the target cell, make ideal
candidates to study the endocytic processes.
Enveloped viruses such as Herpesviruses enter cells either by
direct fusion between viral envelope and the plasma membrane or
by pH-dependent fusion between the viral envelope with the
endosomal membrane, followed by trafficking to the nucleus to
initiate infection [38,39]. The route of viral entry can differ
between cell types [40–42]. Kaposi’s sarcoma-associated herpes-
virus (KSHV) is a c2-herpesvirus implicated as the causative agent
of Kaposi’s sarcoma (KS) and primary effusion lymphoma (PEL).
KS lesions are primarily composed of KSHV-infected spindle cells
with endothelial markers, suggesting that the in vivo targets of
KSHV might be endothelial cells [43]. Previous studies have
shown that KSHV infects fibroblasts via clathrin-mediated
endocytosis, and that microtubules are not required for virus
internalization but required for the trafficking of viral particles
[44,45]. In addition, KSHV entry induces RhoA GTPase, and
rearrangements of both microtubules and the actin cytoskeleton in
fibroblasts [46], and RhoA GTPase is important for virus entry in
HEK293 cells [47] and association of viral particles with
microtubules in dermal microvascular cells (DMVEC) [48].
Nevertheless, in these studies the actin cytoskeleton was found to
be involved in neither virus internalization nor virus trafficking
though others have shown a potential role for the actin
cytoskeleton in clathrin-mediated endocytosis [5,13,14,16]. It is
possible that the requirement for actin dynamics during endocy-
tosis may differ considerably among different cell types. In
addition, KSHV entry and trafficking, as well as the role of actin
cytoskeleton in clathrin-mediated endocytosis in endothelial cells,
have not been extensively examined so far.
To better understand the potential role of the actin cytoskeleton
in KSHV infection in endothelial cells, we have used an
immunofluorescence-based assay (IFA) to visualize viral capsids
during KSHV entry and trafficking in the target cells. This assay
does not rely on the expression of any viral genes, but instead
directly visualizes the accumulation of viral capsids at the nuclear
membrane as an indicator of successful viral entry and trafficking.
To distinguish between plasma membrane fusion and endocytosis,
cells were treated with inhibitors of endosomal acidification before
and during infection. In addition, cells were examined for the
presence of enveloped viral particles at the early stage of KSHV
infection. The results suggested endocytosis as the primary route of
entry used by KSHV to infect primary human umbilical vein
endothelial cells (HUVEC). Additional studies indicated that
clathrin-mediated endocytosis is the major route of KSHV entry
into endothelial cells, and KSHV infection induces dynamic
rearrangement of actin cytoskeleton. Both KSHV viral particles
and transferrin were observed to colocalize with actin filaments
and markers of endosomal maturation. Disruption of the actin
cytoskeleton and inhibition of regulators of actin nucleation such
as Rho GTPases and Arp2/3 complex with chemical agents
profoundly reduced viral entry and trafficking, suggesting that
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Endocytosis, an essential biological process mediating
cellular internalization events, is often exploited by
pathogens for their entry into target cells. The role of
actin cytoskeleton in clathrin-mediated endocytosis in
mammalian cells remains unclear. Kaposi’s sarcoma-
associated herpesvirus (KSHV) is a gammaherpesvirus
linked to the development of Kaposi’s sarcoma, an
endothelial malignancy commonly found in AIDS patients,
and several other malignancies. In this study, we found
that KSHV uses the clathrin-mediated endocytosis pathway
to enter endothelial cells, and this process is regulated by
actin dynamics. We found KSHV particles in early and
recycling endosomes, and lysosomes, which are docked on
actin filaments at the early time points of viral infection.
Similarly, transferrin, which enters cells by clathrin-medi-
ated endocytosis, is associated with actin filaments
together with early and recycling endosomes, and, to a
lesser degree, with late endosomes and lysosomes.
Disruption of the actin cytoskeleton and inhibition of
regulators of actin nucleation such as Rho GTPases and
Arp2/3 complex profoundly blocked KSHV entry and
trafficking in endothelial cells. Together, these results
define an important role for actin dynamics in multiple
endosomal steps during KSHV infection and clathrin-
mediated endocytosis in endothelial cells.
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endosomal steps during KSHV infection and clathrin-mediated
endocytosis in endothelial cells.
Results
Visualization of entry into cells and trafficking to the
perinuclear regions of KSHV particles
To study the mechanism used by KSHV to infect endothelial
cells, an assay to analyze the entry and trafficking of individual
viral particles was developed. KSHV is an enveloped virus, with a
cell-derived membrane enclosing a tegument layer and a central
capsid containing the viral genome [43]. For herpesviruses that
enter the cells via fusion of the viral envelope at the plasma
membrane, the viral envelope glycoproteins are undesirable for
monitoring virus entry and trafficking [38,39]. The fate of the
poorly-characterized tegument during KSHV entry and trafficking
is also unclear [43]. Thus, the component of the virion best suited
for visualizing the entry of a viral particle into cells and subsequent
intracellular trafficking is the viral capsid. The viral capsid remains
intact throughout the infection process and carries the viral
genome to the host nucleus. We used a monoclonal antibody
directed against the KSHV small capsid protein Orf65 to stain the
viral capsid in an IFA. HUVEC inoculated with KSHV were
processed for IFA at various time points post-infection to visualize
the Orf65+ capsids, actin filaments, and the cell nucleus. Z-stacks
were acquired with a confocal laser scanning microscope and used
to generate 3D projection XY overview images (Figure 1A and
Video S1) and the corresponding cross-sectional YZ images
(Figure 1B and Video S2). Images were further magnified to show
the nucleus and individual viral particles (Figure 1C and D, and
Videos S3 and S4). Within 4 h post-infection (hpi), we observed a
large number of viral capsids in the range of 10–70 particles per
cell at the perinuclear region. We quantified the total number of
viral particles reaching the perinuclear region as an indication of
successful viral entry and trafficking.
The entry of enveloped viruses such as herpesviruses can occur
by two different routes: fusion of the viral envelope with the
plasma membrane followed by delivery of the viral particles into
the host cytoplasm, or by attachment to a cellular receptor(s) and
subsequent endocytosis of the receptor proteins and viral particles
[39]. The plasma membrane fusion route is pH-independent,
while viral entry via endocytosis is pH-dependent, and most of
enveloped viruses require low pH in the endosomal vesicle to
initiate viral envelope fusion with the endosomal membrane. In
both cases, the viral capsids are required to traffic to the
perinuclear regions and deliver the viral genome into the nucleus
to complete the infection process. We co-stained the KSHV-
infected cells for both Orf65+ capsids and glycoprotein B (gB), a
viral envelope protein. The cells were visualized with an
epifluorescence microscope. If a virion enters the cells via plasma
membrane fusion, it should lose its envelope at the time of
internalization or membrane fusion. However, if a virion enters
the cells via endocytosis, it should retain its envelope immediately
after internalization but lose it when subsequent fusion with
endosomal membrane occurs. At 5 min post-infection (mpi), over
90% of the Orf65+ particles inside the cells were positive for gB
(Figure S1A). In contrast, at 4 hpi, almost all the Orf65+ particles
inside the cells were negative for gB (Figure S1B). As expected, at
both time points, 100% of the Orf65+ particles outside the cells
were positive for gB (Figure S1A and B). These results suggest that
KSHV likely enters endothelial cells by endocytosis rather than
plasma membrane fusion.
Inhibition of endosomal acidification prevents entry and
trafficking of KSHV particles to nucleus
To further analyze the role of endocytosis in KSHV entry into
endothelial cells, we used a number of chemical inhibitors of
endosomal acidification. NH4Cl is an acidotropic weak-base
amine used to nonspecifically increase intravesicular pH [49].
Monensin is a sodium ionophore that is able to cross membranes
and bind monovalent cations, resulting in an increase in
                                            
Figure 1. Accumulation of Orf65+ viral particles at the nucleus of a KSHV-infected endothelial cell. HUVEC were infected with KSHV and
stained for Orf65+ viral capsids (red), actin cytoskeleton (green), and nuclei (blue) at 4 hpi. (A–B) An overview of a HUVEC infected by KSHV shown in
a XY section (A, also see Video S1 for supporting information) and the corresponding YZ cross-section (B, also see Video S2 for supporting
information). (C–D) Magnified 3D-projection image of the cell nucleus (C, also see a 3-D projection image in Video S3) and the corresponding cross-
section of nucleus (D, also see Video S4 for supporting information).
doi:10.1371/journal.ppat.1000512.g001
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vacuolar ATPase and specifically prevents acidification of
endosomal vesicles [51]. HUVEC pretreated with inhibitors for
1 h were inoculated with KSHV in the presence of the inhibitors,
fixed at 8 hpi, and stained for Orf65+ capsids and nuclei. The cells
were then visualized with an epifluorescence microscope, and the
percentage of the nuclei with at least one Orf65+ particle as well as
the total number of viral particles per nucleus was counted
(Figure 2). While other methods such as infectivity and reporter
assays have been used for monitoring the effects of inhibitors on
viral entry and trafficking, they often rely on the expression of viral
and reporter genes, and thus, can not distinguish the entry events
of single versus multiple viral particles. In contrast, this method
directly measures the entry and trafficking of individual viral
particles to the perinuclear region. As shown in Figure 2A, B, D,
E, G, and H, all inhibitors of endosomal acidification tested
significantly reduced the total number of nuclei bearing at least
one Orf65+ viral particle in a dose-dependent manner, suggesting
that endocytosis rather than plasma membrane fusion, is the
primary route of entry into HUVEC used by KSHV. These results
are consistent with a previous study using viral infectivity as a
method to monitor KSHV entry of human fibroblasts [44]. The
effect of inhibition of endosomal acidification becomes more
apparent when the absolute numbers of viral particles successfully
reaching the nucleus is quantified (Figure 2C, F and I). The nuclei
of untreated cells had significantly more Orf65+ viral particles
than the nuclei from cells treated with inhibitors. To ensure that
the observed results were not due to the side effects of the
inhibitors, we examined the viability of the cells. HUVEC were
subjected to the same treatments with inhibitors and stained with
propidium iodide (PI). None of the inhibitors increased the
number of PI+ cells even at the highest concentrations used
(Figure 2B, E and H, and Figure S2). These chemical inhibitors
also efficiently inhibited the endocytic trafficking of AlexaFluor
488-transferrin, thus demonstrating their effectiveness in inhibiting
endosomal maturation (Figure 2J). Together, these results suggest
that KSHV requires endosomal acidification to efficiently infect
endothelial cells and traffic to the perinuclear region.
Inhibition of clathrin-coated pits assembly prevents entry
and trafficking of viral particles to the nucleus
Mammalian cells utilize multiple endocytic pathways, including
macropinocytosis, clathrin-mediated endocytosis, caveolae-medi-
ated endocytosis, and a poorly understood non-clathrin, non-
caveolae-mediated endocytosis pathway [4]. During clathrin-
mediated endocytosis, clathrin-coated pits assemble on the
cytoplasmic side of the plasma membrane in response to
internalization signals from the receptor [52]. Hypertonic media
has been shown to inhibit the formation of clathrin-coated pits at
the plasma membrane, while the cationic amphiphilic agent
chlorpromazine causes misassembly of clathrin-coated pits and
inhibits clathrin-mediated endocytosis [53]. The role of the
clathrin-mediated endocytosis pathway during KSHV entry into
HUVEC was analyzed by adding dextrose at 100 to 300 mM to
the media to generate hypertonic conditions, or by treating the
cells with chlorpromazine at 1 to 15 mg/ml. Because of the high
toxicity, cells treated with chlorpromazine were fixed and stained
for Orf65+ capsids at 2 hpi. Under these conditions, both
inhibitors had minimal toxicity (Figure 3B and E, and Figure
S3). As shown in Figure 3A, B, D and E, inhibition of clathrin
assembly by either dextrose or chlorpromazine significantly
reduced the total number of nuclei bearing at least one Orf65+
viral particle. In addition, inhibition of clathrin assembly also
reduced the absolute number of viral particles reaching each
nucleus (Figure 3C and F). The inhibitors also efficiently inhibited
the internalization of AlexaFluor 488-transferrin, which is
internalized by cells through clathrin-mediated endocytosis
(Figure 3G); however, they did not inhibit the internalization of
Cholera Toxin B (CTB), which is internalized by cells through
caveolae-mediated endocytosis (Figure 3H). CTB binds GM1
ganglioside and triggers its internalization by caveolae/lipid raft-
mediated endocytosis [54–56]. Thus, internalization of AlexaFluor
488-CTB was used as an indicator for caveolae/lipid raft-
mediated endocytosis. As expected, inhibitors of caveolae-
mediated endocytosis prevented the internalization of CTB (see
below). These results indicated that dextrose and chlorpromazine
specifically inhibited clathrin- but not caveolae-mediated endocy-
tosis. Furthermore, in a separate experiment, we found colocaliza-
tion of KSHV capsids with clathrin (Figure 4A, and Videos S5, S6,
S7 and S8) and AlexaFluor 488-transferrin (Figure 4B, and Videos
S9, S10, S11 and S12). Together, these results suggest that KSHV
entry of endothelial cells is primarily mediated by clathrin-
mediated endocytosis.
Inhibition of caveolae/lipid raft-mediated endocytosis
does not prevent the entry and trafficking of KSHV
particles
Several viruses such as HIV-1, SV40, Ebola virus, Marburg
virus, polyoma virus and echovirus use caveolae/lipid raft-
mediated endocytosis to infect cells [57]. EBV entry into
lymphocytes also requires cholesterol [58]. Endothelial cell
membranes are highly enriched in caveolae, and uptake of
albumin for transcytosis by these cells is facilitated by caveolae-
mediated endocytosis [59,60], suggesting that caveolae-mediated
endocytosis in endothelial cells is a highly efficient process that
could be exploited by viruses for entry into cells. We examined the
involvement of caveolae-mediated endocytosis in KSHV entry
into HUVEC. The chemical agents filipin, nystatin, and methyl-b-
cyclodextrin (MbCD) deplete cholesterol from the plasma
membrane and prevent caveolae/lipid raft-mediated endocytosis
[57]. These agents were used at different concentrations to
determine the role of caveolae/lipid rafts in KSHV entry. As
shown in Figure 5, none of these inhibitors had any effect on
KSHV entry into HUVEC. The percentage of nuclei in the drug-
treated cells bearing at least one Orf65+ viral particle was similar
to the untreated controls (Figure 5A, B, D, E, G, and H). Similarly,
the absolute number of viral particles attached to each nucleus was
not affected by any of the inhibitors (Figure 5C, F and I). As
controls, the inhibitors of caveolae/lipid raft-mediated endocytosis
effectively prevented the internalization of CTB resulting in
membrane accumulation of the marker (Figure 5J). These results
indicate that KSHV was not prevented from entering the cells and
trafficking to the perinuclear region though the chemicals
successfully inhibited caveolae/lipid raft-mediated endocytosis.
These results are consistent with a previous study showing that
nystatin and MbCD do not have any effect on KSHV entry into
fibroblasts [44]. However, they contradict a later report showing
that MbCD affects the association with microtubules and
intracellular trafficking of viral particles in DMVEC [48]. Thus,
there might be an alternative route for trafficking of KSHV
particles in HUVEC.
KSHV induces dynamic remodeling of the actin
cytoskeleton during entry into endothelial cells
While the actin cytoskeleton was not involved in KSHV entry
and trafficking in fibroblasts [44], recombinant KSHV gB was
sufficient to induce the protrusion of lamellipodia and filopodia
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PLoS Pathogens | www.plospathogens.org 4 July 2009 | Volume 5 | Issue 7 | e1000512Figure 2. Inhibition of endosomal acidification reduces the entry and trafficking of KSHV particles to the perinuclear region. (A, D,
and G) HUVEC were treated with chemical inhibitors of endosomal acidification at indicated doses for 1 h prior to inoculation with KSHV. Cells were
inoculated with KSHV in the presence of inhibitors, fixed at 8 hpi, and stained for Orf65+ viral particles (red) and nuclei (blue). (B, E and H) The total
number of nuclei bearing at least one Orf65+ particle was determined and calculated as Orf65+ nuclei (%). In parallel experiments, cells were
subjected to the same treatments and evaluated for viability by PI staining. (C, F and I) The total number of Orf65+ particles docked at each nucleus
was determined. (J) Inhibition of endosomal acidification reduces the internalization of AlexaFluor 488-transferrin. HUVEC were pretreated with
inhibitors of clathrin assembly for 1 h prior to exposure to AlexaFluor 488-transferrin. The reduced internalization and perinuclear accumulation of
transferrin (green) compared to untreated control cells demonstrates the effective inhibition of endosomal acidification.
doi:10.1371/journal.ppat.1000512.g002
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PLoS Pathogens | www.plospathogens.org 5 July 2009 | Volume 5 | Issue 7 | e1000512Figure 3. Inhibition of clathrin assembly reduces the entry and trafficking of KSHV particles to the perinuclear region. (A and D)
HUVEC were treated with chemical inhibitors of clathrin assembly at the indicated doses for 1 h prior to inoculation with KSHV. Cells were inoculated
with KSHV in the presence of inhibitors, fixed at 8 hpi (dextrose) or 2 hpi (chlorpromazine), and stained for Orf65+ viral particles (red) and nuclei
(blue). (B and E) The total number of nuclei bearing at least one Orf65+ particle was determined and calculated as Orf65+ nuclei (%). In parallel
experiments, cells were subjected to the same treatments and evaluated for viability by PI staining. (C and F) The total number of Orf65+ particles
docked at each nucleus was determined. (G–H) Inhibition of clathrin assembly reduces the internalization of AlexaFluor 488-transferrin (G) but not
AlexaFluor 488-CTB (H). HUVEC were pretreated with inhibitors of clathrin assembly for 1 h prior to exposure to AlexaFluor 488-transferrin or
AlexaFluor 488-CTB. The reduced internalization and perinuclear accumulation of transferrin (green) compared to untreated control cells
demonstrates the effective inhibition of clathrin-mediated endocytosis while the internalization and perinuclear accumulation of CTB (green)
indicates that the inhibitors did not affect caveolae-mediated endocytosis.
doi:10.1371/journal.ppat.1000512.g003
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examined the rearrangements of the actin cytoskeleton during
KSHV infection (Figure 6). Before infection, HUVEC had distinct
actin stress fibers (white arrow head) and cortical actin structures
(white arrow). At as early as 0.5 mpi, we observed the dissolution
of the actin stress fibers and increased intensity of the cortical actin
structures, which continued for over 10 min. However, at 15 mpi,
we started to observe the growth of new actin filaments, and
dissolution of the cortical actin structures. At the same time, we
also observed membrane ruffling, lamellipodia and filopodia (red
arrow). The new actin filaments were shorter and thicker than the
stress fibers observed before viral infection, and were sustained for
up to 120 mpi, at which time point, they resembled distinct actin
tails or spikes (red arrow head). These results indicate that KSHV
induces dynamic remodeling of the actin cytoskeleton at the early
stages of infection in endothelial cells.
Chemical disruption of actin cytoskeleton inhibits KSHV
entry and trafficking in endothelial cells
We further examined the role of actin cytoskeleton in KSHV
entry and trafficking in endothelial cells by using chemicals to
disrupt their dynamics. Latrunculin A reversibly disrupts actin
dynamics by targeting monomeric G-actin and preventing actin
polymerization [61,62]. Cytochalasin D reversibly targets F-actin,
inducing depolymerization of existing actin filaments and
increasing the cellular pool of ADP-bound actin monomers
[63,64]. Jasplakinolide reversibly inhibits normal cellular actin
dynamics by hyperstabilizing actin filaments, preventing depoly-
merization, and depleting the cellular pool of free actin monomers
available for de novo polymerization [65]. Disruption of actin
dynamics did not significantly reduce the total number of nuclei
bearing at least one Orf65+ viral particle (Figure 7B, F and J).
Although these results are consistent with previous observations
that the actin cytoskeleton was not involved in KSHV entry and
trafficking in fibroblasts measured by non-viral particle-based
assays [44], when the total number of viral particles docked at
each nucleus was quantified, the cells treated with the actin-
disrupting agents had significantly fewer viral particles per nucleus
than those of untreated cells (Figure 7A, C, E, G, I and K). In
addition, the effect of inhibition also varied with the actin-
disrupting agents, which could reflect their distinct modes of
action. These results suggest that actin dynamics are essential for
the entry of most KSHV particles; however, it appears that a small
number of viral particles are able to enter the cells even in the
absence of a functional actin cytoskeleton system, which could
partially account for the failure to observe an effect of actin-
disrupting agents on KSHV entry and trafficking when measured
with non-viral particle-based infectivity assays, especially when
high viral multiplicity of infection (MOI) was used [44]. Under our
experimental conditions, we did not observe any effect of these
inhibitors on cell viability (Figure 7B, F and J, and Figure S4).
Examination of the actin cytoskeleton showed that they were
effectively disrupted by all three inhibitors (Figure 7D, H and L).
Internalization of Alexafluor 488-transferrin and accumulation in
the perinuclear region was used as an indicator of active clathrin-
mediated endocytosis. As shown in Figure 7M, internalization of
transferrin was inhibited by the disruption of actin dynamics,
resulting in reduced levels of transferrin in the perinuclear region
of the treated cells, further illustrating the important role of actin
dynamics during endocytosis in endothelial cells.
While disruption of actin dynamics affected the entry of KSHV
particles, our results indicated that its effect on KSHV infectivity
might only be obvious at a low MOI. To confirm these
observations, we infected HUVEC at 10 and 2 MOI. Since there
is no plaque assay for KSHV, we quantified viral MOI based on
the number of internalized viral particles per cell. To track viral
infectivity, we stained the cells for LANA and counted the
percentage of LANA-positive cells. As expected, cytochalasin D
and jasplakinolide effectively reduced the average numbers of viral
particles per nuclei (Figure 8A). At a high MOI (10), these
inhibitors did not have any effects on the percentage of cells
containing at least one viral particle (Figure 8B), as well as viral
infectivity measured by the percentage of LANA-positive cells
(Figure 8C). In contrast, at a low MOI, both cytochalasin D and
jasplakinolide effectively reduced the percentage of cells containing
at least one viral particle (Figure 8B) and viral infectivity
Figure 4. Colocalization of Orf65+ KSHV particles with markers of clathrin-mediated endocytosis during KSHV infection of
endothelial cells. (A) HUVEC were inoculated with KSHV, fixed at 1 hpi and stained for clathrin heavy chain (red) and Orf65+ viral particles (green).
(B) HUVEC were infected with KSHV and simultaneously labeled with Alexafluor 488-transferrin (green). Cells were fixed at 1 hpi and stained for
Orf65+ viral particles (red). Regions highlighted in the squares in the upper images are shown as enlarged 3D-projection images in the lower panels.
Areas of colocalization of red and green signals are revealed as yellow. For corresponding 3D projection of colocalization of Orf65+ particles with
clathrin, see Videos S5, S6, S7 and S8. For corresponding 3D projection of colocalization of Orf65+ particles with transferrin, see Videos S9, S10, S11
and S12.
doi:10.1371/journal.ppat.1000512.g004
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perinuclear region. (A, D and G) HUVEC were treated with chemicals to deplete membrane cholesterol and inhibit caveolae/lipid raft-mediated
endocytosis at the indicated doses for 1 h. Cells were inoculated with KSHV in the presence of inhibitors, fixed at 8 hpi, and stained for Orf65+ viral
particles (red) and nuclei (blue). (B, E and H) The total number of nuclei bearing at least one Orf65+ viral particle was determined. (C, F and I) The total
number of Orf65+ viral particles docked at each nucleus was determined. (J) Inhibition of caveolae/lipid raft-mediated endocytosis reduces the
internalization of AlexaFluor 488-CTB. HUVEC were pretreated with inhibitors of caveolae/lipid raft-mediated endocytosis for 1 h prior to exposuret o
AlexaFluor 488-CTB. The reduced internalization and increased membrane accumulation of CTB (green) compared to untreated control cells
demonstrates the effective inhibition of caveolae/lipid raft-mediated endocytosis.
doi:10.1371/journal.ppat.1000512.g005
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KSHV infectivity is MOI-dependent.
Chemical inhibition of regulators of actin nucleation
prevents the entry and trafficking of KSHV particles to
the nucleus
The Rho family of small GTPases such as Rho, Rac and Cdc42
are important regulators of actin cytoskeletal assembly and
organization, as well as intracellular trafficking events during
endocytosis [66]. Rho induces the formation of stress fibers, while
activation of Rac and Cdc42 induces the polymerization of actin
and the formation of a network of actin filaments underlying the
plasma membrane [67]. Considering these known functions, Rho
GTPases are excellent candidates for mediating the signaling
between actin and endocytic traffic [68], and may therefore be
involved in the endocytic entry and trafficking of KSHV.
Clostridium difficile Toxin B (CdTB) glucosylates and inactivates
Rho GTPases, leading to the disruption of actin dynamics [69]. A
previous study showed that KSHV infection of HEK293 cells
activated RhoA GTPase and treatment with CdTB inhibited the
internalization of KSHV DNA in fibroblasts and DMVEC [47].
However, whether these effects were mediated by actin dynamics
and whether the same effects are also present in HUVEC remain
unclear. To examine the role of Rho GTPases in KSHV entry of
HUVEC, cells were treated with CdTB at different concentrations
before and during infection with KSHV. CdTB significantly
reduced the total number of nuclei bearing at least one Orf65+
viral particle (Figure 9A and B). The absolute number of Orf65+
viral particles per nucleus was also reduced in a dose-dependent
fashion (Figure 9A and C). As expected, treatment with CdTB led
to the disruption of the actin cytoskeleton (Figure 9D); however, it
did not affect the viability of the cells (Figure 9B and Figure S5A).
These results implicate a role for Rho GTPases in KSHV entry
and trafficking to the nucleus.
Following the activation of Rho GTPases, actin filament
assembly is regulated by N-WASP and the Arp2/3 complex. N-
WASP activity is required for the activation of Arp2/3. Both
Arp2/3 and N-WASP are recruited to sites of clathrin-mediated
endocytosis [27,70]. Arp2/3 binds to existing actin filaments and
directly nucleates new actin filaments to form a branched network
[27]. Wiskostatin is a cell-permeable chemical that inhibits N-
WASP by stabilizing the auto-inhibited conformation, and thus
preventing the activation of the Arp2/3 complex [71]. To further
investigate the role of de novo actin assembly in viral entry and
trafficking, HUVEC were pretreated with wiskostatin, infected
with KSHV, and stained for Orf65+ capsids. At 25 mM,
wiskostatin decreased the total number of nuclei with at least
one Orf65+ viral particle (Figure 9E and F). In addition, the
absolute number of viral particles docked at each nucleus was
reduced in wiskostatin-treated cells as compared to the untreated
cells (Figure 9G). Similar to CdTB, treatment with wiskostatin also
led to the disruption of the actin cytoskeleton (Figure 9H) but it
had minimal effect on cell viability (Figure 9F and Figure S5B).
Thus, the regulation of actin polymerization through the WASP
family members and Arp2/3 activation is required for KSHV
particles to enter HUVEC and traffic to the perinuclear region.
These results are consistent with those of Figure 7, and Figure 9A,
B, C and D, and demonstrate the importance of de novo actin
assembly and regulation of actin dynamics during KSHV entry.
Figure 6. KSHV infection of endothelial cells induces actin dynamics and rearrangements of the actin cytoskeleton. HUVEC were
infected with KSHV and stained for actin cytoskeleton (green) and nuclei (blue) at different time points post-infection. Actin stress fibers (while arrow
head) and cortical actin structures (white arrow) were visible before viral infection. KSHV infection disrupted actin stress fibers and induced more
cortical actin structures at the early stage of infection (,15 mpi). However, cortical actin structures started to dissolve accompanying the
reappearance of short and thick actin filaments resembling actin tails/spikes (red arrow head) after 15 mpi. Membrane ruffling, lamellipodia and
filopodia were visible after 15 mpi (red arrow head).
doi:10.1371/journal.ppat.1000512.g006
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different endosomal steps during KSHV entry and
trafficking in endothelial cells
While a previous study has shown that disruption of lipid raft
with MbCD and nystatin enhanced KSHV internalization but
inhibited subsequent microtubule-mediated trafficking of viral
particles in DMVEC [48], our results have shown that neither
inhibitor has any effect on the internalization and trafficking of
viral particles but actin cytoskeleton-disrupting agents do. We
speculated that actin dynamics might be involved in the
endosomal sorting and/or intracellular trafficking of KSHV
particles in HUVEC. It has been shown that the role of actin in
endocytosis is variable in mammalian cells depending upon the cell
type and/or the ligand/receptor. To further confirm the role of
actin dynamics in clathrin-mediated endocytosis during KSHV
entry and trafficking in endothelial cells, HUVEC were infected
with KSHV for 30 min, fixed and stained for Orf65+ capsids,
actin filaments, microtubules and the cell nucleus. As shown in
confocal images (Figure 10A), ORF65+ viral particles were closely
associated with both actin fibers and microtubules.
We next sought to determine at what point during the viral
entry and trafficking process actin might be involved. In a time-
course experiment, HUVEC were inoculated with KSHV and
fixed at 2, 5, 15, 30, and 60 mpi. Figure 10B reveals
colocalization of actin filaments with ORF65+ KSHV particles
at all time points examined. The association of KSHV particles
with actin filaments peaked at around 10–15 mpi reaching over
90% of all viral particles before it started to drop (Figure 10C).
Interestingly, we observed the association of viral particles with
actin filaments as late as 4 hpi albeit endocytosis is a relative
rapid process. However, such association with actin filaments at
the later time points of infection might simply reflect the
unsynchronized nature of the infection. Nevertheless, these results
confirmed a potential role for actin dynamics in multiple steps of
clathrin-mediated endocytosis, and KSHV entry and trafficking
in endothelial cells.
To further identify the stage of endocytosis during KSHV entry
and trafficking in endothelial cells that might be regulated by actin
dynamics, HUVEC were infected with KSHV, and stained for
markers of endosomes as well as Or65+ KSHV particles and actin
filaments. The image in Figure 10D reveals the colocalization of
Orf65+ viral capsids, actin filaments, and EEA1, a marker for the
early endosome (Video S13). Figure 10E reveals the association of
viral capsids with actin filaments, and Rab11, a marker for the
recycling endosome (Video S14). Figure 10F demonstrates the
colocalization of viral capsids with actin filaments, and LAMP-1, a
marker for the late endosome/lysosome (Video S15). These results
suggest that actin dynamics are involved in multiple steps of
endocytosis and endosomal trafficking of KSHV, from the early
endosome through the late endosome/lysosome.
Figure 7. Disruption of actin dynamics reduces the entry and
trafficking of KSHV particles to the perinuclear region. (A, E and
I) HUVEC were treated with chemicals to disrupt actin dynamics at the
indicated doses for 1 h. Cells were inoculated with KSHV in the
presence of inhibitors, fixed at 4 hpi, and stained for Orf65+ viral
particles (red) and nuclei (blue). (B, F and J) The total number of nuclei
bearing at least one Orf65+ viral particle was determined and calculated
as Orf65+ nuclei (%). In parallel experiments, cells were subjected to the
same treatments and evaluated for viability by PI staining. (C, G and K)
The total number of Orf65+ viral particles docked at each nucleus was
determined. (D, H and L) Disruption of the actin cytoskeleton by
cytochalasin (D), latrunculin A (H) and jasplakinolide (L). HUVEC were
treated with the inhibitors as described in A, E and I, and stained for the
actin cytoskeleton with AlexaFluor 488-phalloidin except for cells
treated with jasplakinolide, which were stained with an antibody to b-
actin. (M) Disruption of actin dynamics reduces the internalization of
AlexaFluor 488-transferrin. HUVEC were pretreated with chemicals to
disrupt actin dynamics for 1 h prior to exposure to AlexaFluor 488-
transferrin. The reduced internalization and perinuclear accumulation of
transferrin (green) compared to untreated control cells demonstrates
the effective inhibition of clathrin-mediated endocytosis when actin
dynamics are disrupted.
doi:10.1371/journal.ppat.1000512.g007
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endosomal steps during endocytosis in endothelial cells
The association of KSHV particles with both actin filaments
and markers of early and recycling endosome, and lysosome
suggest that actin dynamics might be involved in several post-
internalization steps of endocytosis including endosome sorting
and trafficking in endothelial cells. We further examined the
association of Alexafluor 488-transferrin with actin filaments, and
markers of endosomes (Figure 11). HUVEC were treated with
Alexafluor 488-transferrin for 60 min, fixed and stained for early,
intermediate, and late endosomes as well as actin filaments.
Consistent with previous observations in epithelial cells that the
internalization of transferrin is primarily mediated by transferrin
receptor 1, and once internalized, is sorted to early and recycling
endosomes [72,73], we observed colocalization of 34.8% and
24.5% of Alexafluor 488-transferrin with EEA1 (Figure 11A and
E, and Video S16) and Rab11 (Figure 11B and E, and Videos S17
and S18), respectively. Significantly, as much as 8.6% of
transferrin was colocalized with both EEA1 and actin filaments,
and as much as 3.5% of transferrin was colocalized with both
Rab11 and actin filaments (Figure 11F), suggesting an active role
of actin cytoskeleton in these endosomal steps. We also observed
colocalization of 2.0% of the Alexafluor 488-transferrin with
Rab7, a late endosome marker (Figure 11C and E, and Video
S19), which is consistent with the observation that a small portion
of transferrin is internalized through transferrin receptor 2-
mediated endocytosis and sorted to late endosome/lysosome
[74]. In spite of the low ratio of association of Alexafluor 488-
transferrin with Rab7, surprisingly, as much as 1.9% of the
transferrin was colocalized with both Rab7 and actin filaments
(Figure 11F), indicating that most of the transferrin-containing
Rab7 late endosomes were associated with actin filaments. These
results suggest that actin dynamics might be heavily involved in
late endosomal sorting and/or trafficking. Interestingly, we
observed colocalization of as much as 21.6% of the Alexafluor
488-transferrin with LAMP-1 (Figure 11D and E, and Video S20),
which probably reflected the accumulation of transferrin in
lysosomes over time. Accordingly, only 0.8% of the transferrin
was colocalized with both LAMP-1 and actin filaments
(Figure 11F), suggesting that once reaching the lysosomes, the
transferrin-containing endosomes no longer require actin filaments
for sorting and trafficking. Together, these results suggest that, in
addition to ligand internalization, actin dynamics are also involved
in several other steps of clathrin-mediated endocytosis including
endosomal sorting and trafficking from the early endosome
through the late endosome/lysosome in endothelial cells.
Discussion
The objective of this study was to identify the cellular pathways
and factors that are exploited by KSHV for its entry and
trafficking in endothelial cells. We demonstrate here the utility of
an assay based on immunostaining of viral capsids to visualize
KSHV virions that have successfully entered the cells and docked
at the nucleus. Previous studies relied on the expression viral or
reporter genes as indicators for successful viral entry [44,75].
However, even a single viral particle can potentially enter a cell,
travel to the nucleus, inject viral DNA into the nucleus and initiate
an infection. Thus, these methods are less sensitive and are
confounded by factors that influence the post-entry and trafficking
events. Our results derived from assessing the effects of actin
cytoskeleton disrupting agents on KSHV entry and infection have
clearly illustrated this point (Figures 7 and 8). While we detected
an effect of these inhibitors on the internalization of viral particles,
 
 
Figure 8. Disruption of actin dynamics reduces KSHV infectiv-
ity at low MOI but not high MOI. HUVEC were infected with KSHV at
a high MOI (10) and a low MOI (2). The effects of actin cytoskeleton-
disrupting agents cytochalasin D at 2 mg/ml and jasplakinolide at 1 mM
on the average number of viral particles per nuclei (A), and viral
infectivity based on the percentage of nuclei containing at least one
viral particle (B) or the percentage of LANA-positive cells (C) were
examined.
doi:10.1371/journal.ppat.1000512.g008
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other herpesviruses, KSHV might use more than one route to
enter cells [39]. In this case, inhibition of one pathway might not
affect viral entry via another pathway, resulting in a reduced
number of viral particles entering the cells, but the reduction in
viral/reporter gene expression and viral infectivity will not be
detectable. In fact, it has been demonstrated that if one endocytic
pathway is blocked, the cells can actually upregulate alternate
Figure 9. Disruption of actin regulators reduces the entry and trafficking of KSHV particles to the perinuclear region. (A and E)
HUVEC were treated with chemicals to inhibit Rho GTPase function (A) or Arp2/3 complex activity (E) at the indicated doses for 1 h prior to
inoculation with KSHV. Cells were inoculated with KSHV in the presence of inhibitors, fixed at 4 hpi, and stained for Orf65+ viral particles (red) and
nuclei (blue). (B and F) The total number of nuclei bearing at least one Orf65+ particle was determined. In parallel experiments, cells were subjected
to the same treatments and evaluated for viability by PI staining. (C and G) The total number of Orf65+ particles docked at each nucleus was
determined. (D and H) Disruption of the actin cytoskeleton by CdTB (D) and wiskostatin (H). HUVEC were treated with the inhibitors as described in A
and E, and stained for the actin cytoskeleton with AlexaFluor 488-phalloidin.
doi:10.1371/journal.ppat.1000512.g009
Actin Dynamics Regulate KSHV Entry and Endocytosis
PLoS Pathogens | www.plospathogens.org 12 July 2009 | Volume 5 | Issue 7 | e1000512endocytic routes [76]. In addition, extended exposure to chemical
inhibitors might affect the expression of viral/reporter genes
simply because they are toxic to the cell rather than affecting the
entry or trafficking events. Furthermore, inhibition of the later
steps of endocytosis or endosomal trafficking does not necessarily
prevent viral attachment or early internalization. Finally, removal
of the inhibitors will allow the virus to complete the infection
process if the inhibition is reversible. Certainly, the use of multiple
inhibitors with differing modes of action, in a range of
concentrations, to target a single pathway could impart more
validity to the results of these experiments.
The results of this study clearly demonstrate an essential role for
actin dynamics in KSHV entry and trafficking in endothelial cells.
Endothelial cells are a highly relevant cell type for investigating
KSHV infection as the neoplastic component of KS lesions is
primarily composed of KSHV-infected endothelial cells. Although
our results apparently contradict those in other studies, which did
not identify actin cytoskeleton as a requirement for viral entry and
trafficking [44,45], several explanations can account for the
discrepancy. First of all, if only the total number of KSHV-infected
cells (nuclei with at least one Orf65+ viral capsid) is quantified,
actin-disrupting agents did not seem to prevent viral entry
(Figure 7B, F and J). However, when the absolute number of
viral particles docked per nucleus is quantified, the effect of actin
disruption on viral entry becomes clear (Figure 7C, G and K).
Consistent with these results, when the infection was performed at
a low MOI, the effect of actin-disrupting agents on the total
number of KSHV-infected cells was also demonstrated (Figure 8B).
These results were confirmed by LANA-based infectivity assay
(Figure 8C) albeit the assay could be affected by post-entry events
as discussed above. The results from the experiments using
inhibitors of actin regulators (Figure 9) including CdTB, an
inhibitor of Rho GTPases, and wiskostatin, an inhibitor of N-
WASP, and the observation of viral capsids closely associated with
actin filaments (Figure 10) further confirmed this conclusion. In
fact, these results are consistent with previous observations that
RhoA GTPase is important for KSHV entry in HEK293 cells [47]
and association of viral particles with microtubules in DMVEC
[48]. While these studies have never established a role for actin
dynamics in KSHV entry and trafficking, they, nevertheless,
support an essential role of Rho GTPases in KSHV entry and
trafficking. Together, these observations are consistent with
KSHV induction of actin dynamics during KSHV infection of
endothelial cells, which include the disruption of actin stress fibers
and growth of cortical actin structures at the early stage of KSHV
entry (,15 mpi), and reappearance of actin filaments as actin tails
or spikes at the later stage (.15 mpi) (Figure 6). Secondly, the
results reported here are from experiments that exclusively used
endothelial cells as the target cells for KSHV infection, while
previous studies mainly used fibroblasts and HEK293 cells [44–
48]. Herpesviruses have been found to use different entry
pathways for different types of target cells. For instance, HSV-1
Figure 10. Association of Orf65+ KSHV capsids with actin filaments at different stages of endocytosis during KSHV entry and
trafficking in endothelial cells. (A) HUVEC were infected with KSHV, fixed at 30 mpi, stained for Orf65+ viral capsids (red), actin filaments (green),
and microtubules (white). The area highlighted by the square is enlarged and projected as 3D-projection images in the lower panels, which reveal the
association of Orf65+ viral particles with actin filaments (middle), microtubules (right), and the merged image (left). (B) Time course analysis of the
association Orf65+ viral particles with actin filaments. HUVEC were infected with KSHV, fixed at indicated time points post-infection, and stained for
actin filaments (green), Orf65+ viral particles (red), and nuclei (blue). Highlighted sections in the upper panels were enlarged and shown as 3D-
projection images in the bottom panels, which demonstrate the association of viral capsids with actin filaments at different time points of infection.
(C) Quantification of the kinetics of colocalization of Orf65+ particles with actin filaments. (D–F) Association of Orf65+ viral particles shown in white
with the endosomal protein EEA1 (D), Rab11 (E), or LAMP-1 (F), all in red, and actin filaments in green during KSHV entry of endothelial cells. HUVEC
were prepared as described in (A) and labeled to visualize endosomal proteins, Orf65+ viral capsids and actin filaments. The sections highlighted by
the squares are enlarged in the lower panels. For corresponding 3D projection of colocalization of Orf65+ particles with actin filaments and EEA1,
Rab11 and LAMP-1, see Videos S13, S14 and S15.
doi:10.1371/journal.ppat.1000512.g010
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types through endocytosis [40–42]. Plasma membrane fusion may
not require the participation of actin cytoskeleton for virus
internalization, while endocytosis does. Importantly, while we
have identified clathrin-mediated endocytosis as the major route of
entry used by KSHV to infect endothelial cells, none of the
inhibitors used was able to completely block viral entry, suggesting
the existence of an alternate route of entry in endothelial cells. The
existence of such an alternative route could obviously confound
delineation of the role of cellular components such as the actin
cytoskeleton in regulating KSHV entry and trafficking if
inappropriate assays and controls are used.
Studies of influenza virus entry have demonstrated that viral
entry occurring at the apical surface of cells requires actin, while
viral entry from the basolateral side did not [15,20]. This suggests
that the greater degree of membrane curvature at the apical
surface might necessitate actin dynamic activity to induce
membrane invagination, while the basolateral side does not [17–
19]. In mammalian cells, the actin cytoskeleton is critical for the
maintenance of plasma membrane tension. Chemical disruption of
the entire actin cytoskeleton will relieve membrane tension, which
may in some cases facilitate the formation of membrane
invaginations, and obviate the need for actin polymerization to
drive this step of endocytosis [5,17,18,77]. In addition to forcing
membrane invagination, actin might participate in several other
steps of the endocytic pathway, beginning with the aggregation of
receptors into clathrin-coated pits, scission of the newly-formed
clathrin-coated vesicle away from the plasma membrane,
movement of the clathrin-coated vesicle towards the cell interior,
and trafficking of the vesicle as it matures along the endocytic
pathway. Vesicle trafficking at the cell cortex might be actin-
dependent, prior to transfer of the vesicle to microtubules to
complete the journey to the perinuclear region. In fact,
depolymerization of microtubules did not prevent KSHV binding
or entry, but did prevent the delivery of viral particles to the
nucleus [45]. KSHV infection also activated the formin family
member mDia2 [45]. mDia1 and 2 coordinate actin assembly at
the cell cortex [78], stabilize microtubules independently of actin
nucleating activity [79], and localize to endosomes [80].
While there is evidence suggesting the involvement of the actin
cytoskeleton in the internalization of cargo and initial formation of
endosomes during clathrin-mediated endocytosis in mammalian
cells, information on its role in endosome sorting and trafficking is
limited [5]. In our study, KSHV capsids were observed to
colocalize with actin filaments as well as markers for early and
recycling endosomes, and lysosome. The fact that KSHV capsids
were associated with actin filaments at the early time points of
infection until the docking of the capsids at the nucleus suggests
that actin dynamics might be involved in multiple steps of
internalization, and endosomal sorting and trafficking of viral
particles in endothelial cells. In agreement with these results, we
have also observed colocalization of transferrin with actin
filaments as well as markers of early, recycling and late endosomes,
and to a lesser degree, lysosomes, further supporting the
involvement of actin dynamics in multiple endosomal steps of
clathrin-mediated endocytosis in endothelial cells. Additional
studies are required to delineate the specific mechanism by which
actin dynamics mediate different steps of endosomal sorting and
trafficking during clathrin-mediated endocytosis. In this context,
KSHV can be considered as a useful tool for elucidating the
detailed mechanism of a vital cellular pathway.
Methods and Materials
Cell culture, viral stock and viral infection
Early passage of HUVEC were obtained from Clonetics, Lonza,
and maintained in complete EBM-2 culture media (Allendale, NJ).
KSHV-infected BCP-1 cells isolated from peripheral blood
mononuclear cells of a PEL patient [81] were maintained in
culture in RPMI1640 containing 10% fetal bovine serum (FBS).
Figure 11. Association of Alexafluor 488-transferrin with actin filaments at different stages of endocytosis in endothelial cells. (A–D)
HUVEC were treated with Alexafluor 488-transferrin for 60 min, fixed and stained for actin filaments (red), markers of endosomes (white) and nuclei
(blue). Alexafluor 488-transferrin shown in green was clearly associated with actin filaments and endosomal protein EEA1 (A), Rab11 (B), Rab7 (C) and
LAMP-1 (D). The sections highlighted by the squares are enlarged in the lower or right panels. For corresponding 3D projection of colocalization of
Alexafluor 488-transferrin with actin filaments and EEA1, Rab11, Rab7 and LAMP-1, see Videos S16, S17, S18, S19 and S20. (E–F) Quantification of
colocalization of Alexafluor 488-transferrin with markers of endosomes (E), and with both actin filaments and markers of endosomes (F).
doi:10.1371/journal.ppat.1000512.g011
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starved overnight in RPMI1640. FBS was added back to the
culture media to a final concentration of 10%, together with 12-O-
tetradecanoyl-phorbol-13-acetate (TPA) at 30 ng/ml and sodium
butyrate at 200 mM. At 2 day post-induction, the cells were
washed and the media was replaced with fresh RPMI1640
containing 10% FBS without TPA or sodium butyrate. At 6 days
post-induction, the BCP-1 cells were centrifuged at 1,0006g for
5 min, and the supernatant containing viral particles was
collected, and either used immediately for infection or stored at
4uC.
For viral infection, supernatant from induced BCP-1 cells was
centrifuged for 10 min at 10,0006g. The pellet containing
infectious viral particles was resuspended in one-fourth of the
original volume in EBM-2 media with or without chemical
inhibitors. To infect the cells, HUVEC were seeded onto glass
cover slips overnight to achieve 70–80% confluency. For assays
using chemical inhibitors, cells were pretreated with the inhibitors
in EBM-2 media for 1 h prior to infection. The cells were then
inoculated with the virus preparation and incubated for the
indicated times in the presence of the inhibitors, fixed in 2%
paraformaldehyde and processed for immunostaining of viral
capsids and cellular markers.
Antibodies and chemical inhibitors
A monoclonal antibody isotype IgG2a (clone 6A) to KSHV
small capsid protein (Orf65) was used to stain KSHV capsids [82].
A rabbit antibody to gB was a kind gift of Dr. Bala Chandran at
the Rosalind Franklin University of Medicine an Science,
Chicago, Illinois. A monoclonal antibody to b-actin was obtained
from Sigma (St. Louis, MO). A rat monoclonal antibody to LANA,
and rabbit antibodies to clathrin heavy chain, b-tubulin, EEA1,
Rab11, Rab7 and LAMP-1 were purchased from Abcam (Cam-
bridge, MA). Chemical inhibitors of endosomal acidification
bafilomycin and monensin were purchased from Sigma. NH4Cl
was obtained from Fisher Scientific (Pittsburgh, PA). Chemical
inhibitors of clathrin assembly chlorpromazine and dextrose, and
caveolae/lipid raft-mediated endocytosis filipin, nystatin, and
MbCD were purchased from Sigma. Chemical disruptors of the
actin cytoskeleton latrunculin A and cytochalasin D were from
Sigma while jasplakinolide was from Calbiochem, EMD Chem-
icals, Inc. (Gibbstown, NJ). The chemical inhibitor of WASP
wiskostatin and inhibitor of Rho GTPases CdTB were from
Calbiochem. All chemical inhibitor stock solutions were prepared
according to the manufacturer’s directions. AlexaFluor 488-
phalloidin, AlexaFluor 488-transferrin, AlexaFluor 488-CTB,
secondary antibodies AlexaFluor 568 goat-anti-mouse IgG1,
AlexaFluor 568 and 647 goat anti-mouse IgG2a, and AlexaFluor
488 goat anti-rabbit IgG were from Molecular Probes, Invitrogen
(Carlsbad, CA). DAPI was from BioChemika Ultra, Sigma. PI
labeling kit was obtained from Roche (Nutley, NJ).
Microscopy
For quantification of entry and trafficking of viral particles to
the nuclei, images were acquired using a Zeiss Axiovert 200 M
epifluorescence microscope equipped with a 636 oil immersion
objective (Carl Zeiss Microimaging Inc., Thornwood, NY). Images
were acquired for 5 fields of view per coverslip to allow counting of
Orf65+ capsids docked at nuclei. All experiments were performed
in triplicate. Results are expressed as the mean6SD. For
colocalization experiments, images were acquired with an
Olympus FV1000 scanning confocal microscope equipped with
a6 0 6objective, NA 1.42 (Olympus Life Science, Center Valley,
PA). Z-stacks were acquired at 0.25 mm per slice by sequential
scanning. Olympus FV1000 software was used to generate cross-
sectional images and 3D-projection images (Olympus Life
Science).
Cytotoxicity assay
To examine the cytotoxicity of the inhibitors, HUVEC grown in
48 well plates were treated with the inhibitors at the indicated
concentrations for the stated period of time. One hour prior to
fixation, the cells were labeled with PI to identify nonviable cells.
Cells were washed twice with PBS, fixed with 2% paraformalde-
hyde for 30 min, and counterstained with DAPI. The cells were
visualized with a 206 objective using the Axiovert 200 M
fluorescence microscope. The total number of cells and the
corresponding PI-positive cells from 5 representative fields were
counted, and calculated as PI+ cells (%). In all the experiments,
cells left to air-dry for 20 min to induce cell death were used as
positive controls.
Statistical analysis
All results were expressed as the means6s.d..
Supporting Information
Figure S1 Visualization of enveloped viral particles at the early
and late time points of KSHV infection in endothelial cells.
HUVEC were infected with KSHV and stained for actin
cytoskeleton (green), gB (red), Orf65 (magenta), and nuclei (blue)
at 5 mpi (A) and 4 hpi (B). Over 90% of the viral particles inside
the cells were positive for both gB and Orf65 at the early stage of
infection (A) while almost all the viral particles were only positive
for Orf65 but not gB at the late stage of infection (B). All viral
particles outside the cells were positive for gB and Orf65 at both
early and late time points of infection (A and B).
Found at: doi:10.1371/journal.ppat.1000512.s001 (2.60 MB EPS)
Figure S2 Inhibitors of endosomal acidification do not have any
effect on cell viability. HUVEC were treated with inhibitors of
endosomal acidification at conditions described in Figure 2 and
evaluated for viability by staining with PI and DAPI. (A)
Monensin; (B) NH4Cl; and (C) Bafilomycin. (D) Cells left to air-
dry for 20 min to induce cell death were used as positive controls.
Found at: doi:10.1371/journal.ppat.1000512.s002 (6.68 MB EPS)
Figure S3 Inhibitors of clathrin-mediated endocytosis have
minimal effect on cell viability. HUVEC were treated with
inhibitors of clathrin-mediated endocytosis at conditions described
in Figure 3 and evaluated for viability by staining with PI and
DAPI. (A) Dextrose and (B) Chlorpromazine. (C) Cells left to air-
dry for 20 min to induce cell death were used as positive controls.
Found at: doi:10.1371/journal.ppat.1000512.s003 (4.16 MB EPS)
Figure S4 Actin cytoskeleton-disrupting agents do not have any
effect on cell viability. HUVEC were treated with actin
cytoskeleton-disrupting agents at conditions described in Figure 7
and evaluated for viability by staining with PI and DAPI. (A)
Cytochalasin D; (B) Latrunculin A; and (C) Jasplakinolide. (D)
Cells left to air-dry for 20 min to induce cell death were used as
positive controls.
Found at: doi:10.1371/journal.ppat.1000512.s004 (5.38 MB EPS)
Figure S5 Inhibitors of actin cytoskeleton regulators have
minimal effect on cell viability. HUVEC were treated with
inhibitors of actin cytoskeleton regulators at conditions described
in Figure 9, and evaluated for viability by staining with PI and
DAPI. (A) CdTB; and (B) Wiskostatin. (C) Cells left to air-dry for
20 min to induce cell death were used as positive controls.
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Video S1 An overview of a HUVEC infected by KSHV shown
in a XY section. Cells were stained for Orf65+ viral particles (red),
actin cytoskeleton (green), and nuclei (blue). Images were acquired
with an Olympus FV 1000 scanning confocal microscope using a
606oil immersion objective.
Found at: doi:10.1371/journal.ppat.1000512.s006 (1.71 MB AVI)
Video S2 A cross-section (YZ) view of the same HUVEC
infected by KSHV shown in Video S1.
Found at: doi:10.1371/journal.ppat.1000512.s007 (0.28 MB AVI)
Video S3 A 3D-projection image of the cell nucleus of the same
HUVEC infected by KSHV shown in Video S1.
Found at: doi:10.1371/journal.ppat.1000512.s008 (0.12 MB AVI)
Video S4 A cross-section of the same cell nucleus shown in
Video S3.
Found at: doi:10.1371/journal.ppat.1000512.s009 (0.16 MB AVI)
Video S5 3D-projection images of colocalization of Orf65+ viral
particles with clathrin.
Found at: doi:10.1371/journal.ppat.1000512.s010 (0.73 MB AVI)
Video S6 3D-projection images of colocalization of Orf65+ viral
particles with clathrin.
Found at: doi:10.1371/journal.ppat.1000512.s011 (0.57 MB AVI)
Video S7 3D-projection images of colocalization of Orf65+ viral
particles with clathrin.
Found at: doi:10.1371/journal.ppat.1000512.s012 (0.72 MB AVI)
Video S8 3D-projection images of colocalization of Orf65+ viral
particles with clathrin.
Found at: doi:10.1371/journal.ppat.1000512.s013 (0.67 MB AVI)
Video S9 3D-projection images of colocalization of Orf65+ viral
particles with Alexafluor 488-transferrin.
Found at: doi:10.1371/journal.ppat.1000512.s014 (0.72 MB AVI)
Video S10 3D-projection images of colocalization of Orf65+
viral particles with Alexafluor 488-transferrin.
Found at: doi:10.1371/journal.ppat.1000512.s015 (0.73 MB AVI)
Video S11 3D-projection images of colocalization of Orf65+
viral particles with Alexafluor 488-transferrin.
Found at: doi:10.1371/journal.ppat.1000512.s016 (0.74 MB AVI)
Video S12 3D-projection images of colocalization of Orf65+
viral particles with Alexafluor 488-transferrin.
Found at: doi:10.1371/journal.ppat.1000512.s017 (0.69 MB AVI)
Video S13 A 3D-projection image of colocalization of an
Orf65+ viral particle with an actin filament and EEA1.
Found at: doi:10.1371/journal.ppat.1000512.s018 (0.63 MB AVI)
Video S14 A 3D-projection image of colocalization of Orf65+
viral particles with actin filaments and Rab11.
Found at: doi:10.1371/journal.ppat.1000512.s019 (0.64 MB AVI)
Video S15 A 3D-projection image of colocalization of Orf65+
viral particles with actin filaments and LAMP-1.
Found at: doi:10.1371/journal.ppat.1000512.s020 (0.72 MB AVI)
Video S16 A 3D-projection image of colocalization of Alexa-
fluor 488-transferrin with actin filaments and EEA1.
Found at: doi:10.1371/journal.ppat.1000512.s021 (0.59 MB AVI)
Video S17 A 3D-projection image of colocalization of Alexa-
fluor 488-transferrin with actin filaments and Rab11.
Found at: doi:10.1371/journal.ppat.1000512.s022 (0.61 MB AVI)
Video S18 A 3D-projection image of colocalization of Alexa-
fluor 488-transferrin with actin filaments and Rab11.
Found at: doi:10.1371/journal.ppat.1000512.s023 (0.81 MB AVI)
Video S19 A 3D-projection image of colocalization of Alexa-
fluor 488-transferrin with actin filaments and Rab7.
Found at: doi:10.1371/journal.ppat.1000512.s024 (1.21 MB AVI)
Video S20 A 3D-projection image of colocalization of Alexa-
fluor 488-transferrin with actin filaments and LAMP-1.
Found at: doi:10.1371/journal.ppat.1000512.s025 (0.52 MB AVI)
Acknowledgments
We thank Dr. Bala Chandran for the gB antibody, Dr. Don McEwen for
his help in confocal imaging, Barron Blackman for image processing, and
the technical assistance from members of Dr. Gao’s Laboratory.
Author Contributions
Conceived and designed the experiments: SJG. Performed the experi-
ments: WG SJG. Analyzed the data: WG SJG. Wrote the paper: WG SJG.
References
1. Mosesson Y, Mills GB, Yarden Y (2008) Derailed endocytosis: an emerging
feature of cancer. Nat Rev Cancer 8: 835–850.
2. Gruenberg J, van der Goot FG (2006) Mechanisms of pathogen entry through
the endosomal compartments. Nat Rev Mol Cell Biol 7: 495–504.
3. Rappoport JZ (2008) Focusing on clathrin-mediated endocytosis. Biochem J 412:
415–423.
4. Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature
422: 37–44.
5. Kaksonen M, Toret CP, Drubin DG (2006) Harnessing actin dynamics for
clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 7: 404–414.
6. Smythe E, Ayscough KR (2006) Actin regulation in endocytosis. J Cell Sci 119:
4589–4598.
7. Ascough KR (2004) Endocytosis: Actin in the driving seat. Curr Biol 14:
R124–126.
8. Engqvist-Goldstein AE, Drubin DG (2003) Actin assembly and endocytosis:
from yeast to mammals. Annu Rev Cell Dev Biol 19: 287–332.
9. Kaksonen M, Toret CP, Drubin DG (2005) A modular design for the clathrin-
and actin-mediated endocytosis machinery. Cell 123: 305–320.
10. Fujimoto LM, Roth R, Heuser JE, Schmid SL (2000) Actin assembly plays a
variable, but not obligatory role in receptor-mediated endocytosis in mammalian
cells. Traffic 1: 161–171.
11. Lamaze C, Fujimoto LM, Yin HL, Schmid SL (1997) The actin cytoskeleton is
required for receptor-mediated endocytosis in mammalian cells. J Biol Chem
272: 20332–20335.
12. Salisbury JL, Condeelis JS, Satir P (1980) Role of coated vesicles, microfilaments,
and calmodulin in receptor-mediated endocytosis by cultured B lymphoblastoid
cells. J Cell Biol 87: 132–141.
13. Roth MG (2007) Integrating actin assembly and endocytosis. Dev Cell 13:
3–4.
14. Merrifield CJ, Qualmann B, Kessels MM, Almers W (2004) Neural Wiskott
Aldrich Syndrome Protein (N-WASP) and the Arp2/3 complex are recruited to
sites of clathrin-mediated endocytosis in cultured fibroblasts. Eur J Cell Biol 83:
13–18.
15. Gottlieb TA, Ivanov IE, Adesnik M, Sabatini DD (1993) Actin microfilaments
play a critical role in endocytosis at the apical but not the basolateral surface of
polarized epithelial cells. J Cell Biol 120: 695–710.
16. Yarar D, Waterman-Storer CM, Schmid SL (2005) A dynamic actin
cytoskeleton functions at multiple stages of clathrin-mediated endocytosis. Mol
Biol Cell 16: 964–975.
17. Dai J, Sheetz MP (1995) Regulation of endocytosis, exocytosis, and shape by
membrane tension. Cold Spring Harb Symp Quant Biol 60: 567–571.
18. Dai J, Sheetz MP (1999) Membrane tether formation from blebbing cells.
Biophys J 77: 3363–3370.
19. Karl I, Bereiter-Hahn J (1999) Tension modulates cell surface motility: A
scanning acoustic microscopy study. Cell Motil Cytoskeleton 43: 349–359.
20. Sun X, Whittaker GR (2007) Role of the actin cytoskeleton during influenza
virus internalization into polarized epithelial cells. Cell Microbiol 9: 1672–
1682.
Actin Dynamics Regulate KSHV Entry and Endocytosis
PLoS Pathogens | www.plospathogens.org 16 July 2009 | Volume 5 | Issue 7 | e100051221. Merrifield CJ, Feldman ME, Wan L, Almers W (2002) Imaging actin and
dynamin recruitment during invagination of single clathrin-coated pits. Nat Cell
Biol 4: 691–698.
22. Merrifield CJ, Perrais D, Zenisek D (2005) Coupling between clathrin-coated-pit
invagination, cortactin recruitment, and membrane scission observed in live
cells. Cell 121: 593–606.
23. Bretscher A, Edwards K, Fehon RG (2002) ERM proteins and merlin:
integrators at the cell cortex. Nat Rev Mol Cell Biol 3: 586–599.
24. Weed SA, Parsons JT (2001) Cortactin: coupling membrane dynamics to cortical
actin assembly. Oncogene 20: 6418–6434.
25. Kiuchi T, Ohashi K, Kurita S, Mizuno K (2007) Cofilin promotes stimulus-
induced lamellipodium formation by generating an abundant supply of actin
monomers. J Cell Biol 177: 465–476.
26. Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, et al. (1998) Cofilin
phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin
reorganization. Nature 393: 809–812.
27. Goley ED, Welch MD (2006) The ARP2/3 complex: an actin nucleator comes
of age. Nat Rev Mol Cell Biol 7: 713–726.
28. Chhabra ES, Higgs HN (2007) The many faces of actin: matching assembly
factors with cellular structures. Nat Cell Biol 9: 1110–1121.
29. Qualmann B, Kessels MM (2008) Actin nucleation: putting the brakes on Arp2/
3. Curr Biol 18: R420–423.
30. Hao M, Maxfield FR (2000) Characterization of rapid membrane internaliza-
tion and recycling. J Biol Chem 275: 15279–15286.
31. Mayor S, Presley JF, Maxfield FR (1993) Sorting of membrane components
from endosomes and subsequent recycling to the cell surface occurs by a bulk
flow process. J Cell Biol 121: 1257–1269.
32. Presley JF, Mayor S, Dunn KW, Johnson LS, McGraw TE, et al. (1993) The
End2 mutation in CHO cells slows the exit of transferrin receptors from the
recycling compartment but bulk membrane recycling is unaffected. J Cell Biol
122: 1231–1241.
33. Presley JF, Mayor S, McGraw TE, Dunn KW, Maxfield FR (1997) Bafilomycin
A1 treatment retards transferrin receptor recycling more than bulk membrane
recycling. J Biol Chem 272: 13929–13936.
34. Schwiegelshohn B, Presley JF, Gorecki M, Vogel T, Carpentier YA, et al. (1995)
Effects of apoprotein E on intracellular metabolism of model triglyceride-rich
particles are distinct from effects on cell particle uptake. J Biol Chem 270:
1761–1769.
35. Dabiri GA, Sanger JM, Portnoy DA, Southwick FS (1990) Listeria monocyto-
genes moves rapidly through the host-cell cytoplasm by inducing directional
actin assembly. Proc Natl Acad Sci U S A 87: 6068–6072.
36. Kocks C, Gouin E, Tabouret M, Berche P, Ohayon H, et al. (1992) L.
monocytogenes-induced actin assembly requires the actA gene product, a
surface protein. Cell 68: 521–531.
37. Tilney LG, Portnoy DA (1989) Actin filaments and the growth, movement, and
spread of the intracellular bacterial parasite, Listeria monocytogenes. J Cell Biol
109: 1597–1608.
38. Smith GA, Enquist LW (2002) Break ins and break outs: viral interactions with
the cytoskeleton of Mammalian cells. Annu Rev Cell Dev Biol 18: 135–161.
39. Spear PG, Longnecker R (2003) Herpesvirus entry: an update. J Virol 77:
10179–10185.
40. Nicola AV, Hou J, Major EO, Straus SE (2005) Herpes simplex virus type 1
enters human epidermal keratinocytes, but not neurons, via a pH-dependent
endocytic pathway. J Virol 79: 7609–7616.
41. Nicola AV, Straus SE (2004) Cellular and viral requirements for rapid endocytic
entry of herpes simplex virus. J Virol 78: 7508–7517.
42. Nicola AV, McEvoy AM, Straus SE (2003) Roles for endocytosis and low pH in
herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol
77: 5324–5332.
43. Greene W, Kuhne K, Ye F, Chen J, Zhou F, et al. (2007) Molecular biology of
KSHV in relation to AIDS-associated oncogenesis. Cancer Treat Res 133:
69–127.
44. Akula SM, Naranatt PP, Walia NS, Wang FZ, Fegley B, et al. (2003) Kaposi’s
sarcoma-associated herpesvirus (human herpesvirus 8) infection of human
fibroblast cells occurs through endocytosis. J Virol 77: 7978–7990.
45. Naranatt PP, Krishnan HH, Smith MS, Chandran B (2005) Kaposi’s sarcoma-
associated herpesvirus modulates microtubule dynamics via RhoA-GTP-
diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to
the nucleus. J Virol 79: 1191–1206.
46. Sharma-Walia N, Naranatt PP, Krishnan HH, Zeng L, Chandran B (2004)
Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 envelope glyco-
protein gB induces the integrin-dependent focal adhesion kinase-Src-phospha-
tidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrange-
ments. J Virol 78: 4207–4223.
47. Veettil MV, Sharma-Walia N, Sadagopan S, Raghu H, Sivakumar R, et al.
(2006) RhoA-GTPase facilitates entry of Kaposi’s sarcoma-associated herpesvi-
rus into adherent target cells in a Src-dependent manner. J Virol 80:
11432–11446.
48. Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Caballero A, et al.
(2007) Lipid rafts of primary endothelial cells are essential for Kaposi’s sarcoma-
associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-
kinase and RhoA-GTPases critical for microtubule dynamics and nuclear
delivery of viral DNA but dispensable for binding and entry. J Virol 81:
7941–7959.
49. Ferreira DF, Santo MP, Rebello MA, Rebello MC (2000) Weak bases affect late
stages of Mayaro virus replication cycle in vertebrate cells. J Med Microbiol 49:
313–318.
50. Inabayashi M, Miyauchi S, Kamo N, Jin T (1995) Conductance change in
phospholipid bilayer membrane by an electroneutral ionophore, monensin.
Biochemistry 34: 3455–3460.
51. Bowman EJ, Siebers A, Altendorf K (1988) Bafilomycins: a class of inhibitors of
membrane ATPases from microorganisms, animal cells, and plant cells. Proc
Natl Acad Sci U S A 85: 7972–7976.
52. Marsh M, McMahon HT (1999) The structural era of endocytosis. Science 285:
215–220.
53. Wang LH, Rothberg KG, Anderson RG (1993) Mis-assembly of clathrin lattices
on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol
123: 1107–1117.
54. Merritt EA, Sixma TK, Kalk KH, van Zanten BA, Hol WG (1994) Galactose-
binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin
(CT). Mol Microbiol 13: 745–753.
55. Pang H, Le PU, Nabi IR (2004) Ganglioside GM1 levels are a determinant of
the extent of caveolae/raft-dependent endocytosis of cholera toxin to the Golgi
apparatus. J Cell Sci 117: 1421–1430.
56. Reed RA, Mattai J, Shipley GG (1987) Interaction of cholera toxin with
ganglioside GM1 receptors in supported lipid monolayers. Biochemistry 26:
824–832.
57. Fielding CJ, Fielding PE (2003) Relationship between cholesterol trafficking and
signaling in rafts and caveolae. Biochim Biophys Acta 1610: 219–228.
58. Katzman RB, Longnecker R (2003) Cholesterol-dependent infection of Burkitt’s
lymphoma cell lines by Epstein-Barr virus. J Gen Virol 84: 2987–2992.
59. Schnitzer JE, Oh P, Jacobson BS, Dvorak AM (1995) Caveolae from luminal
plasmalemma of rat lung endothelium: microdomains enriched in caveolin,
Ca(2+)-ATPase, and inositol trisphosphate receptor. Proc Natl Acad Sci U S A
92: 1759–1763.
60. Schubert W, Frank PG, Razani B, Park DS, Chow CW, et al. (2001) Caveolae-
deficient endothelial cells show defects in the uptake and transport of albumin in
vivo. J Biol Chem 276: 48619–48622.
61. Coue M, Brenner SL, Spector I, Korn ED (1987) Inhibition of actin
polymerization by latrunculin A. FEBS Lett 213: 316–318.
62. Spector I, Shochet NR, Kashman Y, Groweiss A (1983) Latrunculins: novel
marine toxins that disrupt microfilament organization in cultured cells. Science
219: 493–495.
63. Goddette DW, Frieden C (1986) Actin polymerization. The mechanism of
action of cytochalasin D. J Biol Chem 261: 15974–15980.
64. Sampath P, Pollard TD (1991) Effects of cytochalasin, phalloidin, and pH on the
elongation of actin filaments. Biochemistry 30: 1973–1980.
65. Bubb MR, Senderowicz AM, Sausville EA, Duncan KL, Korn ED (1994)
Jasplakinolide, a cytotoxic natural product, induces actin polymerization and
competitively inhibits the binding of phalloidin to F-actin. J Biol Chem 269:
14869–14871.
66. Symons M, Rusk N (2003) Control of vesicular trafficking by Rho GTPases.
Curr Biol 13: R409–418.
67. Tapon N, Hall A (1997) Rho, Rac and Cdc42 GTPases regulate the
organization of the actin cytoskeleton. Curr Opin Cell Biol 9: 86–92.
68. Foerg C, Ziegler U, Fernandez-Carneado J, Giralt E, Merkle HP (2007)
Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells
corresponds with activities of Rho-GTPases. Pharm Res 24: 628–642.
69. Just I, Fritz G, Aktories K, Giry M, Popoff MR, et al. (1994) Clostridium difficile
toxin B acts on the GTP-binding protein Rho. J Biol Chem 269: 10706–10712.
70. Benesch S, Polo S, Lai FP, Anderson KI, Stradal TE, et al. (2005) N-WASP
deficiency impairs EGF internalization and actin assembly at clathrin-coated
pits. J Cell Sci 118: 3103–3115.
71. Peterson JR, Bickford LC, Morgan D, Kim AS, Ouerfelli O, et al. (2004)
Chemical inhibition of N-WASP by stabilization of a native autoinhibited
conformation. Nat Struct Mol Biol 11: 747–755.
72. Lakadamyali M, Rust MJ, Zhuang X (2006) Ligands for clathrin-mediated
endocytosis are differentially sorted into distinct populations of early endosomes.
Cell 124: 997–1009.
73. Trischler M, Stoorvogel W, Ullrich O (1999) Biochemical analysis of distinct
Rab5- and Rab11-positive endosomes along the transferrin pathway. J Cell Sci
112(Pt 24): 4773–4783.
74. Johnson MB, Chen J, Murchison N, Green FA, Enns CA (2007) Transferrin
receptor 2: evidence for ligand-induced stabilization and redirection to a
recycling pathway. Mol Biol Cell 18: 743–754.
75. Pan H, Xie J, Ye F, Gao SJ (2006) Modulation of Kaposi’s sarcoma-associated
herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple
mitogen-activated protein kinase pathways during primary infection. J Virol 80:
5371–5382.
76. Damke H, Baba T, van der Bliek AM, Schmid SL (1995) Clathrin-independent
pinocytosis is induced in cells overexpressing a temperature-sensitive mutant of
dynamin. J Cell Biol 131: 69–80.
77. Sheetz MP, Dai J (1996) Modulation of membrane dynamics and cell motility by
membrane tension. Trends Cell Biol 6: 85–89.
78. Eisenmann KM, Harris ES, Kitchen SM, Holman HA, Higgs HN, et al. (2007)
Dia-interacting protein modulates formin-mediated actin assembly at the cell
cortex. Curr Biol 17: 579–591.
Actin Dynamics Regulate KSHV Entry and Endocytosis
PLoS Pathogens | www.plospathogens.org 17 July 2009 | Volume 5 | Issue 7 | e100051279. Bartolini F, Moseley JB, Schmoranzer J, Cassimeris L, Goode BL, et al. (2008)
The formin mDia2 stabilizes microtubules independently of its actin nucleation
activity. J Cell Biol 181: 523–536.
80. Wallar BJ, Deward AD, Resau JH, Alberts AS (2007) RhoB and the mammalian
Diaphanous-related formin mDia2 in endosome trafficking. Exp Cell Res 313:
560–571.
81. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, et al. (1996) KSHV
antibodies among Americans, Italians and Ugandans with and without Kaposi’s
sarcoma. Nat Med 2: 925–928.
82. Gao SJ, Deng JH, Zhou FC (2003) Productive lytic replication of a recombinant
Kaposi’s sarcoma-associated herpesvirus in efficient primary infection of primary
human endothelial cells. J Virol 77: 9738–9749.
Actin Dynamics Regulate KSHV Entry and Endocytosis
PLoS Pathogens | www.plospathogens.org 18 July 2009 | Volume 5 | Issue 7 | e1000512